Peroxisome Proliferator-Activated Receptors: Role of Isoform Gamma in the Antineoplastic Effect of Iodine in Mammary Cancer
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
775-786
Author(s):
R. E. Nunez-Anita, M. Cajero-Juarez and C. Aceves
FAK and p53 Protein Interactions
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
11
Page:
617-619
Author(s):
Vita M. Golubovskaya and William G. Cance
Aptamers Against Cell Surface Receptors: Selection, Modification and Application
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
4107-4116
Author(s):
J. Wang and G. Li
Nucleic Acid Aptamers Against Protein Kinases
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
4152-4158
Author(s):
L. Cerchia and V. de Franciscis
Ovulation Inducing Agents and Cancer Risk: Review of Literature
Journal:
Current Drug Safety
Volume:
6
Page:
250-258
Author(s):
Gianna Gabriella Impicciatore and Gian Mario Tiboni
Drug Combinations Enhancing the Antineoplastic Effects of Erlotinib in High-Grade Glioma
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
6
Page:
384-394
Author(s):
Georg Karpel-Massler, Christian R. Wirtz and Marc-Eric Halatsch
Ribonucleases, Nucleases and Antiangiogenins in Antiproliferative Activities
Journal:
Current Signal Transduction Therapy
Volume:
6
Page:
363-382
Author(s):
Josef Matousek
Evolutionary Significance of Iodine
Journal:
Current Chemical Biology
Volume:
5
Page:
155-162
Author(s):
Sebastiano Venturi
Thyroid: Iodine Beyond the Thyronines
Journal:
Current Chemical Biology
Volume:
5
Page:
163-167
Author(s):
Guillermo J. Juvenal, Lisa Thomasz, Romina Oglio, Marina Perona, Mario A. Pisarev, Luiciano Rossich and Leonardo Salvarredi
Antiproliferative Effects of Molecular Iodine in Cancers
Journal:
Current Chemical Biology
Volume:
5
Page:
168-176
Author(s):
Pompilio Elio Torremante and Harald Rosner